On Halloween 2019, a constitutional argument against the process for challenging patents not only convinced a federal appellate court but also inspired the judges to offer their own fix to the statute.
Read More
The Indiana Family and Social Service Administration’s Office of Medicaid Policy and Planning estimates that 5% to 20% of eligible members would be prescribed weight-loss medications.
The U.S. Food and Drug Administration, after intense public pressure and a lawsuit, is reconsidering its declaration barely two weeks ago that a shortage of the appetite-suppressing drugs Mounjaro and Zepbound—both made by Indianapolis-based Eli Lilly and Co.—is over, a temporary about-face that will allow pharmacies to keep selling unbranded copies.
A group representing companies that made copycat versions of Eli Lilly and Co.’s weight-loss drugs has sued the U.S. Food and Drug Administration over the agency’s decision to remove Lilly’s medications from its shortage list.
Just one month after settling with a South Carolina medical spa that was selling knockoff versions of its popular diabetes and weight-loss drugs, Eli Lilly and Co. is going after other sellers.
The ruling potentially opens the door to hundreds of Lilly employees over 40 years old who have been denied promotions for which they feel they were qualified.
A Nevada-based biotech company is suing Eli Lilly and Co., saying the Indianapolis-based drugmaker is refusing to pay royalties on patented technology it claims is used in Lilly’s pending new treatment for Alzheimer’s disease.
A Texas woman has agreed to plead guilty to leading a conspiracy to defraud Indianapolis-based drugmaker Eli Lilly and Co. out of more than $600,000 in false prescription savings cards.
A federal judge has overturned a $176.5 million jury verdict against Eli Lilly and Co., finding that the Indianapolis-based drugmaker did not infringe on the patents of a competitor in developing a treatment for migraine headaches.
Eli Lilly and Co. has filed lawsuits against 10 companies it accuses of selling unauthorized versions of its diabetes drug Mounjaro, Bloomberg News reported Tuesday.
Eli Lilly and Co. and the maker of diabetes drug Ozempic are being sued in federal court in Louisiana for allegedly failing to warn consumers and physicians about the risk of “severe gastrointestinal events” resulting from the use of two diabetes drugs.
Eli Lilly and Co. has agreed to pay $13.5 million to settle a class-action lawsuit filed six years ago that alleged the Indianapolis-based drugmaker systematically overpriced its insulin.
A federal judge in Illinois has tripled the damages in a jury verdict against Eli Lilly and Co., ruling that the drugmaker must pay $183.7 million in a lawsuit filed by a whistleblower who said the company made false claims about federal Medicaid rebates.
California on Thursday announced it will sue the companies—including Indianapolis-based Eli Lilly and Co.—that make and promote most of the nation’s insulin.
A group of Boone County residents filed legal action Tuesday against the city of Lebanon, accusing the municipality of violating state and local zoning law when it annexed 5,200 acres of land and created a new zoning district for a manufacturing and tech hub.
With a game-changing grant of $4 million from the Lilly Endowment Inc., a long-discussed idea for creating a support network to help individuals reentering society after a period of incarceration is becoming a reality.
Eli Lilly and Co. illegally deducted millions of dollars from employee paychecks to pay for company vehicles and extra time off, a former sales representative claims in a federal lawsuit.
Indiana Gov. Eric Holcomb on Wednesday defended his signing of a near-total abortion ban this month and brushed off fears of business and talent attraction consequences in the wake of statements from major homegrown employers.
The administration of President Joe Biden and one of Indiana’s largest employers have condemned the state’s new ban on abortions, with the White House calling it another extreme attempt by Republicans to trample women’s rights.
An Illinois jury has ordered Indianapolis-based Eli Lilly and Co. to pay $61 million in damages in a lawsuit filed eight years ago by a whistleblower who said the company made false claims about rebates to the federal Medicaid program.
Eli Lilly and Co. is one of hundreds of U.S. companies being sued in the recent trend in litigation: excessive fees on 401(k) retirement plans.